Zacks: Analysts Anticipate Ventas, Inc. (VTR) to Announce $0.95 Earnings Per Share
Brokerages expect Ventas, Inc. (NYSE:VTR) to post earnings per share of $0.95 for the current fiscal quarter, Zacks reports. Three analysts have provided estimates for Ventas’ earnings, with the highest EPS estimate coming in at $0.97 and the lowest estimate coming in at $0.93. Ventas reported earnings of $1.03 per share during the same quarter last year, which suggests a negative year over year growth rate of 7.8%. The firm is expected to announce its next earnings results on Friday, February 8th.
According to Zacks, analysts expect that Ventas will report full-year earnings of $4.06 per share for the current year, with EPS estimates ranging from $4.04 to $4.08. For the next fiscal year, analysts anticipate that the company will report earnings of $3.92 per share, with EPS estimates ranging from $3.73 to $4.07. Zacks Investment Research’s earnings per share calculations are an average based on a survey of research firms that cover Ventas.
Ventas (NYSE:VTR) last posted its quarterly earnings results on Friday, October 26th. The real estate investment trust reported $0.99 earnings per share for the quarter, beating analysts’ consensus estimates of $0.97 by $0.02. Ventas had a net margin of 19.90% and a return on equity of 4.56%. The company had revenue of $936.54 million for the quarter, compared to the consensus estimate of $920.19 million. During the same period last year, the company posted $1.71 EPS. The firm’s quarterly revenue was up 4.1% compared to the same quarter last year.
VTR opened at $65.47 on Wednesday. Ventas has a 1-year low of $46.55 and a 1-year high of $65.70. The company has a debt-to-equity ratio of 1.00, a quick ratio of 0.56 and a current ratio of 0.56. The company has a market capitalization of $23.32 billion, a PE ratio of 15.74, a P/E/G ratio of 4.85 and a beta of 0.06.
In related news, EVP T Richard Riney sold 15,288 shares of Ventas stock in a transaction that occurred on Tuesday, November 20th. The shares were sold at an average price of $62.50, for a total transaction of $955,500.00. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. 1.40% of the stock is owned by company insiders.
A number of large investors have recently bought and sold shares of the stock. Loudon Investment Management LLC lifted its position in shares of Ventas by 1.5% in the 2nd quarter. Loudon Investment Management LLC now owns 60,252 shares of the real estate investment trust’s stock worth $3,431,000 after purchasing an additional 900 shares during the period. Pettyjohn Wood & White Inc. lifted its position in shares of Ventas by 1.9% in the 2nd quarter. Pettyjohn Wood & White Inc. now owns 51,268 shares of the real estate investment trust’s stock worth $2,920,000 after purchasing an additional 955 shares during the period. Sheaff Brock Investment Advisors LLC lifted its position in shares of Ventas by 8.1% in the 3rd quarter. Sheaff Brock Investment Advisors LLC now owns 12,797 shares of the real estate investment trust’s stock worth $696,000 after purchasing an additional 960 shares during the period. United Asset Strategies Inc. lifted its position in shares of Ventas by 9.8% in the 2nd quarter. United Asset Strategies Inc. now owns 11,419 shares of the real estate investment trust’s stock worth $650,000 after purchasing an additional 1,016 shares during the period. Finally, IFP Advisors Inc lifted its position in shares of Ventas by 3.4% in the 3rd quarter. IFP Advisors Inc now owns 36,122 shares of the real estate investment trust’s stock worth $1,964,000 after purchasing an additional 1,190 shares during the period. Institutional investors and hedge funds own 85.30% of the company’s stock.
Ventas Company Profile
Ventas, Inc, an S&P 500 company, is a leading real estate investment trust. Its diverse portfolio of approximately 1,200 assets in the United States, Canada and the United Kingdom consists of seniors housing communities, medical office buildings, life science and innovation centers, inpatient rehabilitation and long-term acute care facilities, health systems and skilled nursing facilities.
Further Reading: Why does a company issue an IPO?
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Ventas Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ventas and related companies with MarketBeat.com's FREE daily email newsletter.